Companies / KalVista Pharmaceuticals Inc / Activity
Activity — KalVista Pharmaceuticals Inc
58 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | The PNC Financial Services Group, Inc. 13F manager | Exit | Common stock | $-2.4K | -146 -100.00% | 0 | low |
| Q2 2026 as of | Garner Asset Management Corp 13F manager | Exit | Common stock | $-2.2K | -135 -100.00% | 0 | low |
| Q1 2026 as of | Rhumbline Advisers 13F manager | Add | Common stock | $1.6K | +78 +0.16% | 47,469 0.09% of shares | low |
| Q1 2026 as of | SG Americas Securities, LLC 13F manager | Trim | Common stock | $-527 | -26K -54.55% | 21,828 0.04% of shares | low |
| Q2 2026 as of | SG Americas Securities, LLC 13F manager | Exit | Common stock | $-439 | -22K -100.00% | 0 | low |
| Q1 2026 as of | Sterling Capital Management LLC 13F manager | Trim | Common stock | $-302 | -15 -5.68% | 249 <0.01% of shares | low |
| Q1 2026 as of | Algert Global LLC 13F manager | Exit | Common stock | $-212 | -13K -100.00% | 0 | low |
| Q4 2025 as of | IFP Advisors, Inc 13F manager | Exit | Common stock | $-61 | -5 -100.00% | 0 | low |